NEW YORK (GenomeWeb News) – Tecan today said it has developed a sample preparation system in collaboration with the Translational Genomics Research Institute and the Biodesign Institute at Arizona State University for proteomic biomarker discovery and validation.
The system, based on Tecan's Freedom EVO 200 liquid handling platform, "is a key tool in the research institutes' goal of establishing an industrial-scale biomarker validation facility," Tecan said in a statement.
According to the company, the platform can prepare almost 1,000 samples in less than 24 hours in the Stable Isotope Standards with Capture by Anti-Peptide Antibody, or SISCAPA, workflow developed by Leigh Anderson as a mass spectrometry-based method for biomarker validation.
"During biomarker discovery, we work with 20 to 100 samples, but once we have identified potential biomarkers, verification and clinical validation must be performed where the challenge is to process hundreds, perhaps thousands, of samples," Konstantinos Petritis, associate professor and laboratory head at TGen's Center for Proteomics, said in a statement. "The Tecan system is a comprehensive and flexible proteomic sample preparation platform that successfully integrates and controls many different modules from a range of vendors."